01 1Cambrex Charles City, Inc.
02 1Curia Missouri, Inc.
03 1Curia Wisconsin, Inc.
01 1SDX
02 2Serdexmethylphenidate Chloride
01 3U.S.A
SERDEXMETHYLPHENIDATE CHLORIDE
NDC Package Code : 59116-7530
Start Marketing Date : 2021-03-02
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
SERDEXMETHYLPHENIDATE CHLORIDE
NDC Package Code : 64181-0094
Start Marketing Date : 2011-07-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
SERDEXMETHYLPHENIDATE CHLORIDE
NDC Package Code : 17180-1729
Start Marketing Date : 2011-07-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
A Serdexmethylphenidate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Serdexmethylphenidate, including repackagers and relabelers. The FDA regulates Serdexmethylphenidate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Serdexmethylphenidate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Serdexmethylphenidate supplier is an individual or a company that provides Serdexmethylphenidate active pharmaceutical ingredient (API) or Serdexmethylphenidate finished formulations upon request. The Serdexmethylphenidate suppliers may include Serdexmethylphenidate API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Serdexmethylphenidate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Serdexmethylphenidate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Serdexmethylphenidate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Serdexmethylphenidate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Serdexmethylphenidate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Serdexmethylphenidate suppliers with NDC on PharmaCompass.
We have 2 companies offering Serdexmethylphenidate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
